By reviewing the data and tweets, can we predict if the closing price of $pfe will go upwards or downwards at 2017-02-09? Please indicate either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-01-26,0.4,0.6,-0.3,-0.0,-0.0,0.4,1.6,3.3,3.6,3.7,3.9
2017-01-27,0.2,0.4,-0.5,0.4,0.4,-0.3,0.8,2.4,3.0,3.1,3.3
2017-01-30,0.5,0.6,-0.8,-0.4,-0.4,-0.1,0.8,2.3,3.2,3.3,3.5
2017-01-31,-2.3,0.6,-2.5,1.3,1.3,-1.0,-0.7,0.6,1.7,1.8,2.0
2017-02-01,-0.5,0.1,-1.3,-0.2,0.8,-1.4,-1.5,-0.6,0.7,0.9,1.1
2017-02-02,-0.8,0.0,-1.3,0.2,0.2,-1.1,-1.6,-0.9,0.3,0.7,0.8
2017-02-03,-0.1,0.5,-0.5,1.1,1.1,-1.6,-2.5,-2.1,-1.0,-0.4,-0.4
2017-02-06,-0.7,0.3,-0.9,0.4,0.4,-1.3,-2.6,-2.5,-1.5,-0.9,-0.8
2017-02-07,0.7,0.8,-0.4,-0.5,-0.5,-0.4,-1.7,-2.0,-1.3,-0.4,-0.3
2017-02-08,-0.7,0.7,-0.7,0.2,0.2,-0.3,-1.6,-2.1,-1.6,-0.7,-0.5

2017-01-26: 7 notable stocks going ex-dividend next week $bmo $has $met $pfe $wfc $fast $payx |11 favored high-yield firms within the dow for 2017  $ba $csco $cvx $dia $ibm $ihe $ko $mcd $mrk $pfe $pg $vz $xlk|rt
2017-01-27: rt AT_USER prescribed reading: $jnj swallows actelion, $pfe announces positive ph. 2 data, fda creates new designation |rt AT_USER $pfe says it will move its fast-tracked drug into ph. 3 testing befor
2017-01-28: this promising prostate cancer treatment could be a game-changer AT_USER #stocks $pfe, $alpmy |johnson &amp; johnson too rich for you? try this high-yielding pharma stock instead  $jnj $pfe|$gild and 
2017-01-29: drugmakers plan huge deals in 2017 -- and banks will collect big fees - thestreet $pfe $jpm $gs |rt AT_USER notable earnings jan30 - feb3: tue $aapl $amd $pfe $s $xom $ups $ea; wed $fb $jci; thu $amzn
2017-01-30: rt AT_USER $lly, $pfe keep the earnings ball rolling tomorrow. here's what to expect  $nvo $azn $gild $mrk $¡­|rt AT_USER #earnings expected tues: $aapl $xom $pfe $ma $ups - 5 largest u.s. companies b
2017-01-31: $pfe - trump's criticism of imports adds to drugmakers' headaches -- update |$pfe - trump's criticism of imports adds to drugmakers' headaches -- update |40mg copaxone patent ruling came up on $pfe q&
2017-02-01: investors sell pfizer, inc. $pfe on strength on disappointing earnings |investors sell pfizer, inc. $pfe on strength on disappointing earnings |$pfe pegs continued growth for ibrance on "late adopters
2017-02-02: fortress bio soars after reporting breakthrough with car-t cancer approach  $amgn  $juno $regn $sny $amrn $pfe $tgtx|$amgn inherits what people once said about $pfe: "not nice, but very smart." |rt AT
2017-02-03: dow 30 stock roundup: apple, intel, exxon beat; merck, #pfizer, chevron miss on revenues. read more:  $pfe|rt AT_USER most active #options: $pfe share buyback, $amzn sales growth disappoints, $fb, $aa
2017-02-06: rt AT_USER rare, deadly lung cancer finds a big foe: patients with nothing to lose  #ros1 AT_USER $pfe htt¡­|$xom $amzn $googl $avgo $aapl $pfe $cvs $bac $td $wmt $cost $wfc $jnj $ge $gs $tsla $utx $f
2017-02-07: rt AT_USER $pfe commences $5 billion accelerated share repurchase|the zacks analyst blog highlights: apple, exxon mobil, merck, #pfizer and intel - february 6... read more:  $pfe|pfizer, inc. $pfe pos
2017-02-08: united services automobile association sells 56,799 shares of pfizer, inc. $pfe |pfizer, inc. $pfe shares bought by hightower advisors llc |pfizer, inc. $pfe stake raised by eagle global advisors llc 
Answer:
Rise